Jazz Pharmaceuticals (JAZZ) Net Cash Flow Growth (1y) (2011 - 2026)
Jazz Pharmaceuticals (JAZZ) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn | 301.06% |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 15.74 Bn | 13.89 Bn | 934.80 Mn | 181.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 181.93% |
| Dec 31, 2025 | -66.60% |
| Sep 30, 2025 | -84.17% |
| Jun 30, 2025 | -679.28% |
| Mar 31, 2025 | -802.71% |
| Dec 31, 2024 | 16.70% |
| Sep 30, 2024 | 1,479.44% |
| Jun 30, 2024 | -175.92% |
| Mar 31, 2024 | -121.40% |
| Dec 31, 2023 | 353.98% |
| Sep 30, 2023 | -59.26% |
| Jun 30, 2023 | -49.09% |
| Mar 31, 2023 | 388.63% |
| Dec 31, 2022 | 147.11% |
| Sep 30, 2022 | 161.28% |
| Jun 30, 2022 | 118.62% |
| Mar 31, 2022 | -109.53% |
| Dec 31, 2021 | -125.03% |
| Sep 30, 2021 | -390.72% |
| Jun 30, 2021 | -1,538.39% |